No profile data available.
Korsana Biosciences, Inc. (KRSA) is a listed company, based in Waltham, United States, with about 19 full-time employees.
Its largest business segment, License Agreement, brought in 88% of segment revenue in fiscal year 2024. Its market capitalization was $1.54 billion as of October 9, 2026.
Figures from company filings and market data; market data as of October 9, 2026.
Korsana Biosciences, Inc. develops therapeutic antibodies for the treatment of neurodegenerative diseases.
License Agreement, with $1.75 million or 88% of segment revenue in fiscal year 2024. Next: License (13%).
$1.54 billion as of October 9, 2026.